548 related articles for article (PubMed ID: 29762685)
1. Urine Multi-drug Screening with GC-MS or LC-MS-MS Using SALLE-hybrid PPT/SPE.
Lee J; Park J; Go A; Moon H; Kim S; Jung S; Jeong W; Chung H
J Anal Toxicol; 2018 Nov; 42(9):617-624. PubMed ID: 29762685
[TBL] [Abstract][Full Text] [Related]
2. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
[TBL] [Abstract][Full Text] [Related]
3. General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
Broecker S; Herre S; Pragst F
Forensic Sci Int; 2012 May; 218(1-3):68-81. PubMed ID: 22036310
[TBL] [Abstract][Full Text] [Related]
4. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
[TBL] [Abstract][Full Text] [Related]
5. Liquid chromatography-quadrupole-time-of-flight mass spectrometry screening procedure for urine samples in forensic casework compared to gas chromatography-mass spectrometry.
Fels H; Dame T; Sachs H; Musshoff F
Drug Test Anal; 2017 May; 9(5):824-830. PubMed ID: 27373549
[TBL] [Abstract][Full Text] [Related]
6. Detection of gamma-hydroxybutyrate in hair: validation of GC-MS and LC-MS/MS methods and application to a real case.
Bertol E; Argo A; Procaccianti P; Vaiano F; Di Milia MG; Furlanetto S; Mari F
J Pharm Biomed Anal; 2012 Nov; 70():518-22. PubMed ID: 22884787
[TBL] [Abstract][Full Text] [Related]
7. Automated solid-phase extraction-liquid chromatography-tandem mass spectrometry analysis of 6-acetylmorphine in human urine specimens: application for a high-throughput urine analysis laboratory.
Robandt PV; Bui HM; Scancella JM; Klette KL
J Anal Toxicol; 2010 Oct; 34(8):470-5. PubMed ID: 21819792
[TBL] [Abstract][Full Text] [Related]
8. Development of a preparation method to produce a single sample that can be applied to both LC-MS/MS and GC-MS for the screening of postmortem specimens.
Hara K; Waters B; Ikematsu N; Tokuyasu T; Fujii H; Takayama M; Matsusue A; Kashiwagi M; Kubo S
Leg Med (Tokyo); 2016 Jul; 21():85-92. PubMed ID: 27497339
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous quantitation of amphetamines and opiates in human hair by liquid chromatography-tandem mass spectrometry.
Liu HC; Liu RH; Lin DL
J Anal Toxicol; 2015 Apr; 39(3):183-91. PubMed ID: 25564575
[TBL] [Abstract][Full Text] [Related]
10. Urine toxicology screening by liquid chromatography time-of-flight mass spectrometry in a quaternary hospital setting.
Pope JD; Black MJ; Drummer OH; Schneider HG
Clin Biochem; 2021 Sep; 95():66-72. PubMed ID: 33989561
[TBL] [Abstract][Full Text] [Related]
11. Postmortem drug screening by non-targeted and targeted ultra-performance liquid chromatography-mass spectrometry technology.
Rosano TG; Wood M; Swift TA
J Anal Toxicol; 2011 Sep; 35(7):411-23. PubMed ID: 21871149
[TBL] [Abstract][Full Text] [Related]
12. LC-MS-MS vs ELISA: Validation of a Comprehensive Urine Toxicology Screen by LC-MS-MS and a Comparison of 100 Forensic Specimens.
Kahl KW; Seither JZ; Reidy LJ
J Anal Toxicol; 2019 Oct; 43(9):734-745. PubMed ID: 31424082
[TBL] [Abstract][Full Text] [Related]
13. A simple extraction and LC-MS/MS approach for the screening and identification of over 100 analytes in eight different matrices.
Montenarh D; Hopf M; Warth S; Maurer HH; Schmidt P; Ewald AH
Drug Test Anal; 2015 Mar; 7(3):214-40. PubMed ID: 24753436
[TBL] [Abstract][Full Text] [Related]
14. Automated solid-phase extraction-liquid chromatography-tandem mass spectrometry analysis of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human urine specimens: application to a high-throughput urine analysis laboratory.
Robandt PV; Klette KL; Sibum M
J Anal Toxicol; 2009 Oct; 33(8):456-60. PubMed ID: 19874652
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous Screening and Quantification of Basic, Neutral and Acidic Drugs in Blood Using UPLC-QTOF-MS.
Bidny S; Gago K; Chung P; Albertyn D; Pasin D
J Anal Toxicol; 2017 Apr; 41(3):181-195. PubMed ID: 27881618
[TBL] [Abstract][Full Text] [Related]
16. Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening.
Lynch KL; Breaud AR; Vandenberghe H; Wu AH; Clarke W
Clin Chim Acta; 2010 Oct; 411(19-20):1474-81. PubMed ID: 20540936
[TBL] [Abstract][Full Text] [Related]
17. In vivo detection of the new psychoactive substance AM-694 and its metabolites.
Bertol E; Vaiano F; Di Milia MG; Mari F
Forensic Sci Int; 2015 Nov; 256():21-7. PubMed ID: 26295909
[TBL] [Abstract][Full Text] [Related]
18. Illicit Drug Analysis Using Two-Dimension Liquid Chromatography/Tandem Mass Spectrometry.
Mallet C; Botch-Jones S
J Anal Toxicol; 2016 Oct; 40(8):617-627. PubMed ID: 27562967
[TBL] [Abstract][Full Text] [Related]
19. Development of a fully automated toxicological LC-MS(n) screening system in urine using online extraction with turbulent flow chromatography.
Mueller DM; Duretz B; Espourteille FA; Rentsch KM
Anal Bioanal Chem; 2011 Apr; 400(1):89-100. PubMed ID: 21174196
[TBL] [Abstract][Full Text] [Related]
20. The screening of forensic blood, urine, and tissue specimens for xenobiotics using ion-trap liquid chromatography-tandem mass spectrometry.
Johnson RD; Botch SR
J Anal Toxicol; 2011 Mar; 35(2):65-74. PubMed ID: 21396225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
